Alpha Fetoprotein Activity Measurement

2020 ◽  
Author(s):  
Keyword(s):  
Alpha Fetoprotein ◽  
Activity Measurement

Alpha-fetoprotein producing gastric cancer cells lack transcription factor AT-motif binding factor 1 (ATBF1)

2001 ◽  
Vol 120 (5) ◽  
pp. A31-A31
Author(s):  
H KATAOKA ◽  
T JOH ◽  
T OHSHIMA ◽  
Y ITOH ◽  
K SENOO ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Transcription Factor ◽  
Cancer Cells ◽  
Alpha Fetoprotein ◽  
Gastric Cancer Cells ◽  
Binding Factor

Alpha-Fetoprotein and Screening Markers of Congenital Disease

1992 ◽  
Vol 12 (3) ◽  
pp. 481-492 ◽  
Author(s):  
Shan G. Sundaram ◽  
Phillip J. Goldstein ◽  
Saravanan Manimekalai ◽  
Robert E. Wenk
Keyword(s):  
Alpha Fetoprotein ◽  
Congenital Disease

Plasminogen Activator Inhibitor-2 and Alpha-Fetoprotein in Various Liver Disease States

1992 ◽  
Vol 68 (03) ◽  
pp. 374-374
Author(s):  
E Özyılkan ◽  
H Şimşek ◽  
O Özdemir ◽  
B Sivri ◽  
Ş Kirazlı ◽  
...  
Keyword(s):  
Liver Disease ◽  
Plasminogen Activator ◽  
Plasminogen Activator Inhibitor ◽  
Alpha Fetoprotein ◽  
Disease States ◽  
Activator Inhibitor

Determination of Factor XIII Activity and of Factor XIII Inhibitors Using an Ammonium-Sensitive Electrode

1983 ◽  
Vol 50 (02) ◽  
pp. 563-566 ◽  
Author(s):  
P Hellstern ◽  
K Schilz ◽  
G von Blohn ◽  
E Wenzel
Keyword(s):  
Factor Xiii ◽  
Normal Subjects ◽  
The Other ◽  
Activity Measurement ◽  
Factor Xiii Deficiency ◽  
Assay Procedure ◽  
Stabilization Factor ◽  
Release Method ◽  
Sensitive Electrode

SummaryAn assay for rapid factor XIII activity measurement has been developed based on the determination of the ammonium released during fibrin stabilization. Factor XIII was activated by thrombin and calcium. Ammonium was measured by an ammonium-sensitive electrode. It was demonstrated that the assay procedure yields accurate and precise results and that factor XIII-catalyzed fibrin stabilization can be measured kinetically. The amount of ammonium released during the first 90 min of fibrin stabilization was found to be 7.8 ± 0.5 moles per mole fibrinogen, which is in agreement with the findings of other authors. In 15 normal subjects and in 15 patients suffering from diseases with suspected factor XIII deficiency there was a satisfactory correlation between the results obtained by the “ammonium-release-method”, Bohn’s method, and the immunological assay (r1 = 0.65; r2= 0.70; p<0.01). In 3 of 5 patients with paraproteinemias the values of factor XIII activity determined by the ammonium-release method were markedly lower than those estimated by the other methods. It could be shown that inhibitor mechanisms were responsible for these discrepancies.

Sign in / Sign up

Export Citation Format

Share Document